NASDAQ:CPHD - Cepheid Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $52.95 0.00 (0.00 %) (As of 07/16/2018 04:00 PM ET)Previous Close$52.95Today's Range$52.95 - $52.9552-Week Range$25.09 - $53.91VolumeN/AAverage Volume1.25 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileFinancialsAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Cepheid is a molecular diagnostics company. The Company develops, manufactures and markets fully-integrated systems for testing in the Clinical and Non-Clinical markets. The Company's systems enable molecular testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The Company's systems integrate these steps and analyze biological samples in test cartridges. Its primary offering is the GeneXpert system, which integrates sample preparation in addition to Deoxyribonucleic acid (DNA) amplification and detection. The GeneXpert system is designed for a range of user types ranging from reference laboratories and hospital central laboratories to satellite testing locations, such as emergency departments and intensive care units within hospitals, as well as physician offices and other alternate site laboratories. It also offers the SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample. Receive CPHD News and Ratings via Email Sign-up to receive the latest news and ratings for CPHD and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryBiotechnology SectorN/A SymbolNASDAQ:CPHD CUSIP15670R10 Webwww.cepheid.com Phone+1-408-5414191 Debt Debt-to-Equity Ratio0.76 Current Ratio4.30 Quick Ratio3.24 Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-6.88% Return on Equity-11.54% Return on Assets-5.18% Miscellaneous Employees1,700 Outstanding Shares72,890,000Market Cap$0.00 Cepheid (NASDAQ:CPHD) Frequently Asked Questions What is Cepheid's stock symbol? Cepheid trades on the NASDAQ under the ticker symbol "CPHD." How were Cepheid's earnings last quarter? Cepheid (NASDAQ:CPHD) released its quarterly earnings data on Thursday, July, 28th. The scientific and technical instruments company reported $0.05 earnings per share for the quarter, beating analysts' consensus estimates of ($0.14) by $0.19. The scientific and technical instruments company earned $146 million during the quarter, compared to analyst estimates of $145.82 million. Cepheid had a negative return on equity of 11.54% and a negative net margin of 6.88%. The business's quarterly revenue was up 10.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.06) earnings per share. View Cepheid's Earnings History. What is the consensus analysts' recommendation for Cepheid? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cepheid in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Has Cepheid been receiving favorable news coverage? Media coverage about CPHD stock has trended somewhat positive on Monday, according to Accern. The research firm identifies positive and negative media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Cepheid earned a coverage optimism score of 0.09 on Accern's scale. They also gave media coverage about the scientific and technical instruments company an impact score of 45.62 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future. How do I buy shares of Cepheid? Shares of CPHD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Cepheid's stock price today? One share of CPHD stock can currently be purchased for approximately $52.95. How can I contact Cepheid? Cepheid's mailing address is 904 E Caribbean Dr, SUNNYVALE, CA 94089-1189, United States. The scientific and technical instruments company can be reached via phone at +1-408-5414191. MarketBeat Community Rating for Cepheid (NASDAQ CPHD)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 433 (Vote Outperform)Underperform Votes: 425 (Vote Underperform)Total Votes: 858MarketBeat's community ratings are surveys of what our community members think about Cepheid and other stocks. Vote "Outperform" if you believe CPHD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CPHD will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/16/2018 by MarketBeat.com StaffFeatured Article: What does RSI mean?